Portfolio Companies 2026 for Kurma Partners: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.
Kurma Partners accounts for 29 tracked companies with verified cap-table data, 29 of which disclose round sizes totalling $2.8B. The median disclosed raise is $73M, and the largest is Pharvaris at $353M, ahead of Amolyt Pharma ($210M) and Alveus Therapeutics ($197M).
The names that recur most often on these portfolio cap tables are Kurma Partners (29 companies), Andera Partners (7 companies), Bpifrance (7 companies), Idinvest Partners (4 companies), LSP (4 companies), EQT Life Sciences (4 companies). By latest disclosed round, the market skews Series A (9), Series B (9), Series C (7), IPO (1).
Companies tracked: 29
Disclosed funding total: $2.8B across 29 companies
Median disclosed raise: $73M
Largest raise: Pharvaris — $353M
Stage mix: Series A 9 · Series B 9 · Series C 7 · IPO 1
